bleomycin medac
medac gesellschaft für klinische spezialpräparate mbh - bleomicinas - milteliai injekciniam tirpalui - 15000 tv - bleomycin
bleocin
nenurodyta - bleomicinas - milteliai injekciniam tirpalui - 15 mg - bleomycin
bleocel
nenurodyta - bleomicinas - milteliai injekciniam tirpalui - 15000 tv - bleomycin
bleo-cell
lex ano, uab - bleomicinas - milteliai injekciniam tirpalui - 15000 tv - bleomycin
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubicino hidrochloridas - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antinavikiniai vaistai - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
neocones
septodont - neomicinas/benzokainas - dantų lazdelės - 15400 tv/5 mg - neomycin
adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - antinavikiniai vaistai - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris fluorouracilu ir folino suaugusių pacientų su atsinaujino arba ugniai atsparios cd30+ hodžkino limfoma (hl):taip asct, orfollowing bent du prieš terapiją, kai asct arba multi-agent chemoterapija nėra gydymo būdas. sisteminės anaplastic daug ląstelių lymphomaadcetris kartu su ciklofosfamidu, doxorubicin ir prednizolonas (chp) yra nurodyta suaugusių pacientų, kurių anksčiau negydytų sisteminės anaplastic didelių ląstelių limfoma (salcl). adcetris fluorouracilu ir folino suaugusių pacientų su atsinaujino arba ugniai atsparios salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.
polygynax
actiofarma, uab - neomicinas/polimiksino b sulfatas/nistatinas - makšties minkštosios kapsulės - 35000 tv/35000 tv/100000 tv - nystatin, combinations
vincristine teva
teva pharma b.v. - vinkristinas - injekcinis tirpalas - 1 mg/ml - vincristine
vinblastine teva
teva pharma b.v. - vinblastino sulfatas - injekcinis tirpalas - 1 mg/ml - vinblastine